Clinical trials · Boston, MA
Medulloblastoma Recurrent clinical trials in Boston
We’re tracking 3 recruiting medulloblastoma recurrent studies with a site in or near Boston — including Phase 1 and Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Boston
- NCT05096481RecruitingPhase 2
Vaccine for brain tumors in children and young adults
This trial tests a vaccine that may help the immune system fight brain tumors (medulloblastoma, high-grade glioma, and DIPG). It is for patients who have already had standard treatment and whose tumors are still present or have returned.
Boston, MassachusettsAges 3–39 - NCT07390539RecruitingPhase 1
CAR T cells targeting B7-H3 for brain tumors
This trial tests a new type of immune therapy (CAR T cells) that targets a protein called B7-H3 found on some brain tumors. It is for children and young adults with certain brain or spinal cord tumors that have come back after standard treatment, and aims to see if the treatment is safe and effective.
Boston, MassachusettsAges 2–21 - NCT01356290RecruitingPhase 2
Drug combination for recurrent brain tumors in children
This trial tests a combination of antiangiogenic drugs (which block blood supply to tumors) for children with certain brain or spinal tumors that have returned or not responded to standard treatment. The goal is to see if this drug combo can shrink or slow the tumor.
Boston, MassachusettsAges Up to 19 years
Hear when a new Medulloblastoma Recurrent trial opens near Boston, MA
We’ll email you when one opens near Boston, MA — at most once a week, no account needed, unsubscribe anytime.
Medulloblastoma Recurrent trials in other cities
Where these studies are running near Boston
Institutions with a site for the recruiting medulloblastoma recurrent studies listed above.
- Dana-Farber Cancer Institute · 3 studies
- Boston Children's Hospital
What taking part in a medulloblastoma recurrent study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting medulloblastoma recurrent studies in Massachusetts.
Common questions
- Are there medulloblastoma recurrent clinical trials near Boston?
- Yes. We're currently tracking 3 recruiting medulloblastoma recurrent studies with a site near Boston, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a medulloblastoma recurrent study near Boston?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Boston to take part?
- Not necessarily. These studies have a site near Boston, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a medulloblastoma recurrent trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New medulloblastoma recurrent studies open near Boston regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.